Results of docetaxel plus oxaliplatin (DOCOX)±cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Journal of Cancer
Authors: Donald Richards, Darren M. Kocs, Alexander I. Spira, A. David McCollum, Sami Diab, Lanny I. Hecker, Allen Cohn, Feng Zhan, Lina Asmar
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: docetaxel, oxaliplatin, metastatic gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, combination chemotherapy, progression-free survival, KRAS status, EGFR inhibition, neutropenia, adverse events, response rate, overall survival, duration of response, first-line therapy, second-line therapy
Open Access status: closed
OpenAlex ID: W2014908282
